Great Point Partners’s 4D Molecular Therapeutics FDMT Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-350,000	Closed	-$6.32M	–	43
2023 Q2	$6.32M	Buy	+350,000	New	+$6.32M	1.24%	26